Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
August 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Feb 27, 2026
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
Read ↗
Feb 26, 2026
Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification
Femasys IR
Read ↗
Feb 23, 2026
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
GlobeNewswire
Read ↗
Feb 3, 2026
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
Femasys IR
Read ↗
Jan 14, 2026
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
GlobeNewswire
Read ↗
Jan 13, 2026
Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care
GlobeNewswire
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.